-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Therapy for Lower Risk MDS

Program: Education Program
Session: Myelodysplastic Syndromes: What We Have and What We Want
Saturday, December 5, 2020, 9:25 AM-9:30 AM

Hetty E. Carraway, MD, MBA

Cleveland Clinic, Cleveland, OH

Disclosures: Carraway: Abbvie: Other: Independent Advisory Committe (IRC); Jazz: Consultancy, Speakers Bureau; Stemline: Consultancy, Speakers Bureau; Takeda: Other: Independent Advisory Committe (IRC); BMS: Consultancy, Other: Research support, Speakers Bureau; Novartis: Consultancy, Speakers Bureau; ASTEX: Other: Independent Advisory Committe (IRC).

See more of: Myelodysplastic Syndromes: What We Have and What We Want
See more of: Education Program
<< Previous Presentation | Next Presentation >>